Advertisement

Uncategorized

  • May 13: The Week in Cancer News

    First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.

    by Marci A. Landsmann

  • May 6: The Week in Cancer News

    Adolescents and young adult cancer survivors at higher risk for dying from a new cancer diagnosis, and FDA grants full approval to Enhertu for metastatic HER2-postive breast cancer.

    by Eric Fitzsimmons

  • April 29: The Week in Cancer News

    FDA proposes ban on menthol cigarettes, and proton beam therapy on the rise but with growing racial disparity.

    by Thomas Celona

  • April 22: The Week in Cancer News

    Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

    by Kevin McLaughlin

  • T Cells Key to COVID-19 Vaccination Efforts

    Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.

    by Thomas Celona

  • April 8: The Week in Cancer News

    CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist.

    by Kevin McLaughlin

  • April 1: The Week in Cancer News

    Chemo brain may provide clues for long-haul COVID-19, and researchers analyze relationship between obesity and cancer.

    by Marci A. Landsmann

  • March 25: The Week in Cancer News

    FDA approves combination immunotherapy for treating melanoma, and screening tool improves pancreatic cancer detection.

    by Kevin McLaughlin

  • March 18: The Week in Cancer News

    Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast cancer for people with inherited BRCA mutations.

    by Eric Fitzsimmons

  • March 11: The Week in Cancer News

    FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.

    by Kevin McLaughlin